{"gene":"GABRA4","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":2005,"finding":"The transcription factor Egr3 directly binds the GABRA4 promoter and stimulates its activity, mediating seizure-induced up-regulation of the α4 subunit. Egr3 knockout mice show ~50% reduction in GABRA4 mRNA in the hippocampus, and increased Egr3 binding to the GABRA4 promoter accompanies pilocarpine-induced status epilepticus.","method":"Promoter-reporter assays (AAV-driven), transfection in primary hippocampal neurons, ChIP (Egr3 binding to GABRA4 promoter), Egr3 knockout mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (reporter assay, ChIP, KO mice) in a single study with strong mechanistic follow-up","pmids":["16091474"],"is_preprint":false},{"year":1995,"finding":"GABRA4 maps to human chromosome 4p14-q12, placing it within an α2-α4-β1-γ1 gene cluster, consistent with derivation from an ancestral GABAA receptor gene cluster by duplication.","method":"Chromosomal mapping (genomic/Southern blot-based gene mapping)","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 — direct chromosomal mapping, foundational genomic localization replicated across GABAA receptor gene studies","pmids":["7607683"],"is_preprint":false},{"year":2015,"finding":"During alcohol withdrawal, specific microRNAs (miR-186, miR-24, miR-375, and miR-155) bind the 3'UTR of Gabra4 and suppress its expression in cortical neurons; transfection with mimics of these miRNAs downregulates Gabra4, while their inhibitors normalize Gabra4 levels during withdrawal.","method":"RT-PCR, microRNA microarray, miRNA mimics/inhibitors transfection, promoter-reporter construct with Gabra4 3'UTR","journal":"Brain and behavior","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (reporter assay, mimics, inhibitors) but single lab study","pmids":["26357588"],"is_preprint":false},{"year":2022,"finding":"A de novo missense variant in GABRA4 (p.Thr300Ile) located in the pore-forming domain causes accelerated receptor desensitization and abolishes seizure-protective neurosteroid function, as characterized by electrophysiology.","method":"Electrophysiological characterization of mutant GABAA receptor containing α4(Thr300Ile) subunit","journal":"Epilepsia","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro electrophysiology with disease-associated mutant, single lab","pmids":["35152403"],"is_preprint":false},{"year":2024,"finding":"Three additional de novo missense variants in GABRA4 transmembrane domain residues (p.Pro266Leu, p.Thr300Asn, p.Val212Ile) alter sub-microsecond dynamics of the receptor channel as shown by molecular dynamics simulations, corroborating functional disruption of the α4 subunit pore region.","method":"Molecular dynamics (MD) simulations of transmembrane domain variants; clinical exome/genome sequencing","journal":"European journal of human genetics : EJHG","confidence":"Low","confidence_rationale":"Tier 4 — computational MD only; no in vitro electrophysiology for novel variants","pmids":["38565639"],"is_preprint":false},{"year":2020,"finding":"Gabra4 knockout mice display autistic-like behavior, enhanced spatial memory, and reduced susceptibility to pentylenetetrazol-induced seizures; hippocampal transcriptome profiling and interactome network analysis reveal upregulation of the NMDAR system as a converging pathway underlying these phenotypes.","method":"Gabra4 knockout mouse behavioral testing, hippocampal RNA-seq transcriptome profiling, interactome network analysis","journal":"Molecular autism","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined behavioral and molecular phenotypes, multiple readouts, single lab","pmids":["32033586"],"is_preprint":false}],"current_model":"GABRA4 encodes the α4 subunit of GABAA receptors; its transcription is directly regulated by Egr3 binding to the GABRA4 promoter (mediating seizure-induced upregulation) and post-transcriptionally suppressed during alcohol withdrawal by miR-186/miR-24/miR-375 acting on its 3'UTR; the α4 subunit contributes to receptor desensitization kinetics and neurosteroid sensitivity via its pore-forming transmembrane domain, and loss of α4-containing receptors shifts hippocampal synaptic balance toward an upregulated NMDAR system with behavioral consequences including autistic-like phenotypes and altered seizure susceptibility."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing the genomic context of GABRA4 within an α2-α4-β1-γ1 gene cluster on chromosome 4p14-q12 provided the foundational map position and supported the hypothesis that GABAA receptor subunit genes arose by ancestral cluster duplication.","evidence":"Genomic/Southern blot-based chromosomal mapping","pmids":["7607683"],"confidence":"High","gaps":["Cluster co-regulation and functional significance of gene linkage not tested","No expression or functional data for the α4 subunit at this stage"]},{"year":2005,"claim":"Identifying Egr3 as a direct transcriptional activator of GABRA4 resolved how seizure activity rapidly upregulates the α4 subunit, establishing a transcription-factor-to-subunit axis in epileptogenesis.","evidence":"AAV-driven promoter-reporter assays, ChIP of Egr3 at the GABRA4 promoter, Egr3 knockout mice showing ~50% GABRA4 mRNA reduction","pmids":["16091474"],"confidence":"High","gaps":["Other transcription factors contributing to GABRA4 regulation not characterized","Whether Egr3-GABRA4 axis operates similarly outside the hippocampus is unknown"]},{"year":2015,"claim":"Demonstrating that miR-186, miR-24, and miR-375 suppress GABRA4 via its 3′UTR during alcohol withdrawal revealed a post-transcriptional layer of regulation that could explain context-dependent α4 subunit downregulation.","evidence":"miRNA microarray, 3′UTR reporter assays, miRNA mimic/inhibitor transfection in cortical neurons","pmids":["26357588"],"confidence":"Medium","gaps":["Direct binding site mapping for each miRNA within the 3′UTR not performed","In vivo validation of miRNA-mediated GABRA4 suppression during withdrawal is lacking","Single-lab finding not independently replicated"]},{"year":2020,"claim":"Gabra4 knockout mice revealed that loss of α4-containing GABAA receptors shifts hippocampal circuit balance toward NMDAR-dominated excitation, producing autistic-like behavior and paradoxically reduced chemically induced seizure susceptibility.","evidence":"Gabra4 knockout mouse behavioral testing, hippocampal RNA-seq, interactome network analysis","pmids":["32033586"],"confidence":"Medium","gaps":["Causal role of NMDAR upregulation in the behavioral phenotype not tested by pharmacological rescue","Cell-type-specific contributions of α4 loss not resolved","Single-lab study"]},{"year":2022,"claim":"Functional characterization of the disease-associated p.Thr300Ile variant demonstrated that a single residue change in the α4 pore domain is sufficient to accelerate desensitization and eliminate neurosteroid modulation, directly linking GABRA4 to epileptic encephalopathy.","evidence":"Whole-cell patch-clamp electrophysiology of mutant α4-containing GABAA receptors","pmids":["35152403"],"confidence":"Medium","gaps":["In vivo consequences of the variant (knock-in model) not assessed","Only one variant functionally characterized at this stage","Whether loss of neurosteroid sensitivity is the primary pathogenic mechanism versus altered desensitization is unresolved"]},{"year":2024,"claim":"Molecular dynamics simulations of additional transmembrane-domain variants (p.Pro266Leu, p.Thr300Asn, p.Val212Ile) suggested that multiple positions in the α4 pore region are sensitive to missense disruption, broadening the genotype-phenotype landscape.","evidence":"MD simulations of variant transmembrane domains; clinical exome/genome sequencing","pmids":["38565639"],"confidence":"Low","gaps":["No electrophysiological or in vitro functional validation for these three novel variants","Computational predictions not benchmarked against the experimentally characterized Thr300Ile variant","Clinical phenotype-genotype correlations remain preliminary"]},{"year":null,"claim":"It remains unknown how α4-containing GABAA receptors are differentially trafficked to synaptic versus extrasynaptic sites, what structural basis underlies subunit-specific neurosteroid sensitivity, and whether GABRA4 variants cause disease primarily through altered desensitization, impaired neurosteroid modulation, or compensatory NMDAR upregulation.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure of an α4-containing GABAA receptor","Mechanism of α4 subunit trafficking and membrane targeting uncharacterized","Pharmacological rescue strategies for GABRA4 loss-of-function not tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[3,5]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,5]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,5]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,5]}],"complexes":["GABAA receptor"],"partners":["EGR3"],"other_free_text":[]},"mechanistic_narrative":"GABRA4 encodes the α4 subunit of GABAA receptors, contributing to receptor desensitization kinetics, neurosteroid sensitivity, and the balance between inhibitory GABAergic and excitatory glutamatergic neurotransmission. Transcription of GABRA4 is directly activated by the transcription factor Egr3, which binds the GABRA4 promoter and mediates seizure-induced upregulation of the α4 subunit [PMID:16091474], while post-transcriptionally, miR-186, miR-24, and miR-375 suppress GABRA4 expression via its 3′UTR during alcohol withdrawal [PMID:26357588]. De novo missense variants in the pore-forming transmembrane domain (e.g., p.Thr300Ile) accelerate receptor desensitization and abolish neurosteroid-mediated seizure protection, linking GABRA4 dysfunction to epileptic encephalopathy [PMID:35152403]. Loss of α4-containing receptors in Gabra4 knockout mice produces autistic-like behavior, enhanced spatial memory, and reduced seizure susceptibility, with compensatory upregulation of the NMDA receptor system in the hippocampus [PMID:32033586]."},"prefetch_data":{"uniprot":{"accession":"P48169","full_name":"Gamma-aminobutyric acid receptor subunit alpha-4","aliases":["GABA(A) receptor subunit alpha-4","GABAAR subunit alpha-4"],"length_aa":554,"mass_kda":61.6,"function":"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:35355020). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:35355020). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the cell membrane down their electrochemical gradient (PubMed:35355020). GABAARs containing alpha-4 are predominantly extrasynaptic, contributing to tonic inhibition in dentate granule cells and thalamic relay neurons (By similarity). Extrasynaptic alpha-4-containing GABAARs control levels of excitability and network activity (By similarity). GABAAR containing alpha-4-beta-3-delta subunits can simultaneously bind GABA and histamine where histamine binds at the interface of two neighboring beta subunits, which may be involved in the regulation of sleep and wakefulness (PubMed:35355020)","subcellular_location":"Cell membrane; Postsynaptic cell membrane","url":"https://www.uniprot.org/uniprotkb/P48169/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GABRA4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GABRA4","total_profiled":1310},"omim":[{"mim_id":"604852","title":"CHEMOKINE, CXC MOTIF, LIGAND 11; CXCL11","url":"https://www.omim.org/entry/604852"},{"mim_id":"209850","title":"AUTISM","url":"https://www.omim.org/entry/209850"},{"mim_id":"137163","title":"GAMMA-AMINOBUTYRIC ACID RECEPTOR, DELTA; GABRD","url":"https://www.omim.org/entry/137163"},{"mim_id":"137141","title":"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-4; GABRA4","url":"https://www.omim.org/entry/137141"},{"mim_id":"137140","title":"GAMMA-AMINOBUTYRIC ACID RECEPTOR, ALPHA-2; GABRA2","url":"https://www.omim.org/entry/137140"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":9.3},{"tissue":"heart muscle","ntpm":2.4}],"url":"https://www.proteinatlas.org/search/GABRA4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P48169","domains":[{"cath_id":"2.70.170.10","chopping":"71-254","consensus_level":"high","plddt":92.8459,"start":71,"end":254},{"cath_id":"1.20.58.390","chopping":"258-351_519-551","consensus_level":"high","plddt":90.5276,"start":258,"end":551}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P48169","model_url":"https://alphafold.ebi.ac.uk/files/AF-P48169-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P48169-F1-predicted_aligned_error_v6.png","plddt_mean":72.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GABRA4","jax_strain_url":"https://www.jax.org/strain/search?query=GABRA4"},"sequence":{"accession":"P48169","fasta_url":"https://rest.uniprot.org/uniprotkb/P48169.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P48169/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P48169"}},"corpus_meta":[{"pmid":"16091474","id":"PMC_16091474","title":"Egr3 stimulation of GABRA4 promoter activity as a mechanism for seizure-induced up-regulation of GABA(A) receptor alpha4 subunit expression.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16091474","citation_count":86,"is_preprint":false},{"pmid":"7607683","id":"PMC_7607683","title":"Mapping of the alpha 4 subunit gene (GABRA4) to human chromosome 4 defines an alpha 2-alpha 4-beta 1-gamma 1 gene cluster: further evidence that modern GABAA receptor gene clusters are derived from an ancestral cluster.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7607683","citation_count":54,"is_preprint":false},{"pmid":"21422964","id":"PMC_21422964","title":"Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor.","date":"2011","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21422964","citation_count":31,"is_preprint":false},{"pmid":"32033586","id":"PMC_32033586","title":"Transcriptomics of Gabra4 knockout mice reveals common NMDAR pathways underlying autism, memory, and epilepsy.","date":"2020","source":"Molecular autism","url":"https://pubmed.ncbi.nlm.nih.gov/32033586","citation_count":26,"is_preprint":false},{"pmid":"32028044","id":"PMC_32028044","title":"Further evidence of GABRA4 and TOP3B as autism susceptibility genes.","date":"2020","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32028044","citation_count":19,"is_preprint":false},{"pmid":"26357588","id":"PMC_26357588","title":"Downregulation of Gabra4 expression during alcohol withdrawal is mediated by specific microRNAs in cultured mouse cortical neurons.","date":"2015","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/26357588","citation_count":16,"is_preprint":false},{"pmid":"29299688","id":"PMC_29299688","title":"Gamma-aminobutyric acid (GABA) receptors GABRA4, GABRE, and GABRQ gene polymorphisms and risk for migraine.","date":"2018","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/29299688","citation_count":16,"is_preprint":false},{"pmid":"35152403","id":"PMC_35152403","title":"A de novo missense variant in GABRA4 alters receptor function in an epileptic and neurodevelopmental phenotype.","date":"2022","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/35152403","citation_count":14,"is_preprint":false},{"pmid":"38565639","id":"PMC_38565639","title":"De novo variants in GABRA4 are associated with a neurological phenotype including developmental delay, behavioral abnormalities and epilepsy.","date":"2024","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/38565639","citation_count":8,"is_preprint":false},{"pmid":"34526837","id":"PMC_34526837","title":"Investigation the Relationship of Autism Spectrum Disorder and FOXP2, GRIN2B, KATNAL2, GABRA4 Genes.","date":"2021","source":"Noro psikiyatri arsivi","url":"https://pubmed.ncbi.nlm.nih.gov/34526837","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6335,"output_tokens":1451,"usd":0.020385},"stage2":{"model":"claude-opus-4-6","input_tokens":4715,"output_tokens":1892,"usd":0.106313},"total_usd":0.126698,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"The transcription factor Egr3 directly binds the GABRA4 promoter and stimulates its activity, mediating seizure-induced up-regulation of the α4 subunit. Egr3 knockout mice show ~50% reduction in GABRA4 mRNA in the hippocampus, and increased Egr3 binding to the GABRA4 promoter accompanies pilocarpine-induced status epilepticus.\",\n      \"method\": \"Promoter-reporter assays (AAV-driven), transfection in primary hippocampal neurons, ChIP (Egr3 binding to GABRA4 promoter), Egr3 knockout mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (reporter assay, ChIP, KO mice) in a single study with strong mechanistic follow-up\",\n      \"pmids\": [\"16091474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"GABRA4 maps to human chromosome 4p14-q12, placing it within an α2-α4-β1-γ1 gene cluster, consistent with derivation from an ancestral GABAA receptor gene cluster by duplication.\",\n      \"method\": \"Chromosomal mapping (genomic/Southern blot-based gene mapping)\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct chromosomal mapping, foundational genomic localization replicated across GABAA receptor gene studies\",\n      \"pmids\": [\"7607683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"During alcohol withdrawal, specific microRNAs (miR-186, miR-24, miR-375, and miR-155) bind the 3'UTR of Gabra4 and suppress its expression in cortical neurons; transfection with mimics of these miRNAs downregulates Gabra4, while their inhibitors normalize Gabra4 levels during withdrawal.\",\n      \"method\": \"RT-PCR, microRNA microarray, miRNA mimics/inhibitors transfection, promoter-reporter construct with Gabra4 3'UTR\",\n      \"journal\": \"Brain and behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (reporter assay, mimics, inhibitors) but single lab study\",\n      \"pmids\": [\"26357588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A de novo missense variant in GABRA4 (p.Thr300Ile) located in the pore-forming domain causes accelerated receptor desensitization and abolishes seizure-protective neurosteroid function, as characterized by electrophysiology.\",\n      \"method\": \"Electrophysiological characterization of mutant GABAA receptor containing α4(Thr300Ile) subunit\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro electrophysiology with disease-associated mutant, single lab\",\n      \"pmids\": [\"35152403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Three additional de novo missense variants in GABRA4 transmembrane domain residues (p.Pro266Leu, p.Thr300Asn, p.Val212Ile) alter sub-microsecond dynamics of the receptor channel as shown by molecular dynamics simulations, corroborating functional disruption of the α4 subunit pore region.\",\n      \"method\": \"Molecular dynamics (MD) simulations of transmembrane domain variants; clinical exome/genome sequencing\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational MD only; no in vitro electrophysiology for novel variants\",\n      \"pmids\": [\"38565639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Gabra4 knockout mice display autistic-like behavior, enhanced spatial memory, and reduced susceptibility to pentylenetetrazol-induced seizures; hippocampal transcriptome profiling and interactome network analysis reveal upregulation of the NMDAR system as a converging pathway underlying these phenotypes.\",\n      \"method\": \"Gabra4 knockout mouse behavioral testing, hippocampal RNA-seq transcriptome profiling, interactome network analysis\",\n      \"journal\": \"Molecular autism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined behavioral and molecular phenotypes, multiple readouts, single lab\",\n      \"pmids\": [\"32033586\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABRA4 encodes the α4 subunit of GABAA receptors; its transcription is directly regulated by Egr3 binding to the GABRA4 promoter (mediating seizure-induced upregulation) and post-transcriptionally suppressed during alcohol withdrawal by miR-186/miR-24/miR-375 acting on its 3'UTR; the α4 subunit contributes to receptor desensitization kinetics and neurosteroid sensitivity via its pore-forming transmembrane domain, and loss of α4-containing receptors shifts hippocampal synaptic balance toward an upregulated NMDAR system with behavioral consequences including autistic-like phenotypes and altered seizure susceptibility.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GABRA4 encodes the α4 subunit of GABAA receptors, contributing to receptor desensitization kinetics, neurosteroid sensitivity, and the balance between inhibitory GABAergic and excitatory glutamatergic neurotransmission. Transcription of GABRA4 is directly activated by the transcription factor Egr3, which binds the GABRA4 promoter and mediates seizure-induced upregulation of the α4 subunit [PMID:16091474], while post-transcriptionally, miR-186, miR-24, and miR-375 suppress GABRA4 expression via its 3′UTR during alcohol withdrawal [PMID:26357588]. De novo missense variants in the pore-forming transmembrane domain (e.g., p.Thr300Ile) accelerate receptor desensitization and abolish neurosteroid-mediated seizure protection, linking GABRA4 dysfunction to epileptic encephalopathy [PMID:35152403]. Loss of α4-containing receptors in Gabra4 knockout mice produces autistic-like behavior, enhanced spatial memory, and reduced seizure susceptibility, with compensatory upregulation of the NMDA receptor system in the hippocampus [PMID:32033586].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing the genomic context of GABRA4 within an α2-α4-β1-γ1 gene cluster on chromosome 4p14-q12 provided the foundational map position and supported the hypothesis that GABAA receptor subunit genes arose by ancestral cluster duplication.\",\n      \"evidence\": \"Genomic/Southern blot-based chromosomal mapping\",\n      \"pmids\": [\"7607683\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Cluster co-regulation and functional significance of gene linkage not tested\",\n        \"No expression or functional data for the α4 subunit at this stage\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identifying Egr3 as a direct transcriptional activator of GABRA4 resolved how seizure activity rapidly upregulates the α4 subunit, establishing a transcription-factor-to-subunit axis in epileptogenesis.\",\n      \"evidence\": \"AAV-driven promoter-reporter assays, ChIP of Egr3 at the GABRA4 promoter, Egr3 knockout mice showing ~50% GABRA4 mRNA reduction\",\n      \"pmids\": [\"16091474\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Other transcription factors contributing to GABRA4 regulation not characterized\",\n        \"Whether Egr3-GABRA4 axis operates similarly outside the hippocampus is unknown\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that miR-186, miR-24, and miR-375 suppress GABRA4 via its 3′UTR during alcohol withdrawal revealed a post-transcriptional layer of regulation that could explain context-dependent α4 subunit downregulation.\",\n      \"evidence\": \"miRNA microarray, 3′UTR reporter assays, miRNA mimic/inhibitor transfection in cortical neurons\",\n      \"pmids\": [\"26357588\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct binding site mapping for each miRNA within the 3′UTR not performed\",\n        \"In vivo validation of miRNA-mediated GABRA4 suppression during withdrawal is lacking\",\n        \"Single-lab finding not independently replicated\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Gabra4 knockout mice revealed that loss of α4-containing GABAA receptors shifts hippocampal circuit balance toward NMDAR-dominated excitation, producing autistic-like behavior and paradoxically reduced chemically induced seizure susceptibility.\",\n      \"evidence\": \"Gabra4 knockout mouse behavioral testing, hippocampal RNA-seq, interactome network analysis\",\n      \"pmids\": [\"32033586\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Causal role of NMDAR upregulation in the behavioral phenotype not tested by pharmacological rescue\",\n        \"Cell-type-specific contributions of α4 loss not resolved\",\n        \"Single-lab study\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Functional characterization of the disease-associated p.Thr300Ile variant demonstrated that a single residue change in the α4 pore domain is sufficient to accelerate desensitization and eliminate neurosteroid modulation, directly linking GABRA4 to epileptic encephalopathy.\",\n      \"evidence\": \"Whole-cell patch-clamp electrophysiology of mutant α4-containing GABAA receptors\",\n      \"pmids\": [\"35152403\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"In vivo consequences of the variant (knock-in model) not assessed\",\n        \"Only one variant functionally characterized at this stage\",\n        \"Whether loss of neurosteroid sensitivity is the primary pathogenic mechanism versus altered desensitization is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Molecular dynamics simulations of additional transmembrane-domain variants (p.Pro266Leu, p.Thr300Asn, p.Val212Ile) suggested that multiple positions in the α4 pore region are sensitive to missense disruption, broadening the genotype-phenotype landscape.\",\n      \"evidence\": \"MD simulations of variant transmembrane domains; clinical exome/genome sequencing\",\n      \"pmids\": [\"38565639\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No electrophysiological or in vitro functional validation for these three novel variants\",\n        \"Computational predictions not benchmarked against the experimentally characterized Thr300Ile variant\",\n        \"Clinical phenotype-genotype correlations remain preliminary\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how α4-containing GABAA receptors are differentially trafficked to synaptic versus extrasynaptic sites, what structural basis underlies subunit-specific neurosteroid sensitivity, and whether GABRA4 variants cause disease primarily through altered desensitization, impaired neurosteroid modulation, or compensatory NMDAR upregulation.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No cryo-EM or crystal structure of an α4-containing GABAA receptor\",\n        \"Mechanism of α4 subunit trafficking and membrane targeting uncharacterized\",\n        \"Pharmacological rescue strategies for GABRA4 loss-of-function not tested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [3, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"complexes\": [\n      \"GABAA receptor\"\n    ],\n    \"partners\": [\n      \"EGR3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}